Fisher & Paykel Healthcare Corporation Ltd

Common Name
Fisher & Paykel Healthcare
Country
New Zealand
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
7,384
Ticker
FPH
Exchange
NZX
Description
Fisher & Paykel Healthcare Corporation Limited is a leading designer, manufacturer, and marketer of innovative healthcare equipment, primarily aimed at improving patient care and outcomes. This notabl...

Fisher & Paykel Healthcare's GHG Emissions Data Preview

In 2025, Fisher & Paykel Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Fisher & Paykel Healthcare has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Fisher & Paykel Healthcare’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fisher & Paykel Healthcare’s data sources below and access millions more through our Disclosure Search.

a. Fisher & Paykel Healthcare's Annual Report 2025
a. Fisher & Paykel Healthcare's Annual Report 2025
b. Fisher & Paykel Healthcare's Annual Report 2022
b. Fisher & Paykel Healthcare's Annual Report 2022

Insights into Fisher & Paykel Healthcare's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare amounted to 15,527 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare decreased by 4.78%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Fisher & Paykel Healthcare's Scope 1 Emissions Over Time

20202021202220232024202506001.2 k1.8 k2.4 ktCO2e-23%+21%+31%-14%+14%
  • Total Scope 1
  • Year-over-Year Change

What are Fisher & Paykel Healthcare's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Fisher & Paykel Healthcare were 2,295 metric tons of CO₂ equivalent (tCO₂e). a

Has Fisher & Paykel Healthcare reduced its Scope 1 emissions over time?

Since 2020, Fisher & Paykel Healthcare's Scope 1 emissions have increased by 19.91%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 1 emissions increased by 14.01%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Fisher & Paykel Healthcare's Scope 2 emissions?

In 2025, Fisher & Paykel Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 12,406 tCO₂e using the market-based method and 13,232 tCO₂e using the location-based method. a

Has Fisher & Paykel Healthcare reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Fisher & Paykel Healthcare 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Fisher & Paykel Healthcare use for Scope 2 reporting?

In 2025, Fisher & Paykel Healthcare reported its Scope 2 emissions using the market-based method and using the location-based method. a

Fisher & Paykel Healthcare's Scope 2 Emissions Over Time

20202021202220232024202504 k8 k12 k16 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Fisher & Paykel Healthcare's Value Chain Emissions

In 2025, Fisher & Paykel Healthcare reported 266,044 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2025 disclosure of Fisher & Paykel Healthcare includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Fisher & Paykel Healthcare's Scope 3 Emissions Over Time

2020202120222023202420250200 k400 k600 k800 ktCO2e+11%-36%-32%-22%+10%
  • Total Scope 3
  • Year-over-Year Change

What are Fisher & Paykel Healthcare's Scope 3 emissions?

In 2025, Fisher & Paykel Healthcare reported total Scope 3 emissions of 266,044 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 54.64% of these emissions originated from upstream activities such as purchased goods and capital goods, while 45.36% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Fisher & Paykel Healthcare reduced its Scope 3 emissions over time?

Since 2020, Fisher & Paykel Healthcare's Scope 3 emissions have decreased by 59.07%, reflecting a declining long-term trend in Scope 3 emissions over time. a b

Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 3 emissions increased by 10.2%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Fisher & Paykel Healthcare disclose?

In 2025, Fisher & Paykel Healthcare reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Fisher & Paykel Healthcare's Scope 3 emissions?

In 2025, the largest contributors to Fisher & Paykel Healthcare's Scope 3 emissions were: a

  • Use of Sold Products (Cat. 11): 117,249 tCO₂e (44.07%)
  • Purchased Goods and Services (Cat. 1): 88,220 tCO₂e (33.16%)
  • Upstream Transportation and Distribution (Cat. 4): 22,651 tCO₂e (8.51%)

Fisher & Paykel Healthcare's Scope 3 Emissions by Categories

UpstreamTransportation andDistribution(Cat. 4)(8.5%)Use of Sold Products(Cat. 11)(44.1%)Purchased Goods andServices (Cat. 1)(33.2%)

Insights into Fisher & Paykel Healthcare’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Fisher & Paykel Healthcare reported Scope 1 greenhouse gas (GHG) emissions of 2,295 tCO₂e and total revenues of USD 727 millions. This translates into an emissions intensity of 3.16 tCO₂e per millions USD. a

Fisher & Paykel Healthcare's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000100,0001,000,000Scope 1 Emissions (tCO2e)505002,00010,000100,000Revenues (Millions of USD)IMeniconYear: 2023Scope 1: 3,930 tCO2eRevenue: $M 827Scope 1 Intensity: 4.75 tCO2e/$MAzentaYear: 2023Scope 1: 14,399 tCO2eRevenue: $M 665Scope 1 Intensity: 21.65 tCO2e/$MAptargroupYear: 2023Scope 1: 24,660 tCO2eRevenue: $M 3,487Scope 1 Intensity: 7.07 tCO2e/$MStevanato GroupYear: 2023Scope 1: 45,525 tCO2eRevenue: $M 1,201Scope 1 Intensity: 37.90 tCO2e/$MYpsomed HoldingYear: 2024Scope 1: 2,198 tCO2eRevenue: $M 608Scope 1 Intensity: 3.61 tCO2e/$MTop GloveYear: 2023Scope 1: 273,483 tCO2eRevenue: $M 486Scope 1 Intensity: 562.18 tCO2e/$MFielmann GroupYear: 2024Scope 1: 6,362 tCO2eRevenue: $M 2,356Scope 1 Intensity: 2.70 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MCarl Zeiss MeditecYear: 2023Scope 1: 52,493 tCO2eRevenue: $M 2,207Scope 1 Intensity: 23.79 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MConvaTec GroupYear: 2024Scope 1: 12,360 tCO2eRevenue: $M 1,690Scope 1 Intensity: 7.31 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MIIImeik Technology DevelopmentYear: 2023Scope 1: 1,070 tCO2eRevenue: $M 404Scope 1 Intensity: 2.65 tCO2e/$MColtene HoldingYear: 2024Scope 1: 1,607 tCO2eRevenue: $M 276Scope 1 Intensity: 5.82 tCO2e/$MWeigao GroupYear: 2023Scope 1: 2,705 tCO2eRevenue: $M 2,026Scope 1 Intensity: 1.33 tCO2e/$MStraumann HoldingYear: 2024Scope 1: 8,781 tCO2eRevenue: $M 2,765Scope 1 Intensity: 3.18 tCO2e/$MSCHOTT Pharma AG & CoYear: 2024Scope 1: 27,536 tCO2eRevenue: $M 1,069Scope 1 Intensity: 25.76 tCO2e/$MEssilorLuxotticaYear: 2024Scope 1: 116,092 tCO2eRevenue: $M 27,584Scope 1 Intensity: 4.21 tCO2e/$MSartoriusYear: 2023Scope 1: 13,103 tCO2eRevenue: $M 3,758Scope 1 Intensity: 3.49 tCO2e/$MPoly MedicureYear: 2024Scope 1: 2,320 tCO2eRevenue: $M 164Scope 1 Intensity: 14.17 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MAnsellYear: 2024Scope 1: 173,100 tCO2eRevenue: $M 2,475Scope 1 Intensity: 69.94 tCO2e/$MAddLifeYear: 2023Scope 1: 8,491 tCO2eRevenue: $M 960Scope 1 Intensity: 8.84 tCO2e/$MFisher & Paykel HealthcareYear: 2025Scope 1: 2,295 tCO2eRevenue: $M 727Scope 1 Intensity: 3.16 tCO2e/$M

How does Fisher & Paykel Healthcare's GHG emissions intensity compare to its peers?

In 2025, Fisher & Paykel Healthcare reported a Scope 1 emissions intensity of 3.16 tCO₂e per millions USD. Compared to the peer group median of 5.33 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Fisher & Paykel Healthcare rank on GHG emissions intensity within its industry?

In 2025, Fisher & Paykel Healthcare ranked 7 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Fisher & Paykel Healthcare is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Fisher & Paykel Healthcare's Total Carbon Footprint

In 2025, Fisher & Paykel Healthcare reported a total carbon footprint of 281,571 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 9.25% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Fisher & Paykel Healthcare's total carbon footprint was Scope 3 emissions, accounting for 94.49% of the company's total carbon footprint, followed by Scope 2 emissions at 4.7%. a

Want Full Access to Fisher & Paykel Healthcare's GHG Emissions Dataset?
Sign Up